Abstract
Tumor progression can very broadly be def ined as the progression from a less advanced to a more advanced neoplasm, due to the acquisition of genetic or other cell biologic alterations (Fig. 1). Implicit in this definition is the hypothesis that these acquired cellular alterations endow neoplastic cells with a growth advantage that is subsequently selected for in the evolution of the more advanced lesion (1). As such, these acquired alterations are the answers to many critical questions regarding tumor biology. As an example, consider the transformation that occurs when a benign neoplasm progresses to malignancy. Delineating the events that occur during this process could also yield new clinical tools for diagnosis and treatment, while understanding the forces that drive the acquisition of these alterations could yield insights into putative preventive targets.
Simple model of neoplastic progression. Less advanced neoplasms acquire genetic or epigenetic alterations that are selected for during tumor growth, resulting in clonal evolution.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
1
Office of Human Subjects Research
- 2.
2
Laser Capture Microdissection
References
Nowell, P. C. (1976) The clonal evolution of tumor cell populations. Science 194, 23–28.
Cotran, R. S., Kumar, V., Collins, T., and Robbins, S. L., Eds. (1999) Robbins Pathologic Basis of Disease. Saunders, Philadelphia.
Ponten, J. and Guo, Z. (1998) Precancer of the human cervix. Cancer Surv. 32, 201–229.
Wahl, G. M. and Carr, A. M. (2001) The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat. Cell. Biol. 3, E277–E286.
Davidoff, A. M., Kerns, B. J., Pence, J. C., Marks, J. R., and Iglehart, J. D. (1991) p53 alterations in all stages of breast cancer. J. Surg. Oncol. 48, 260–267.
Done, S. J., Arneson, N., Ozcelik, H., Redston, M., and Andrulis, I. L. (1998) p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. Cancer Res. 58, 785–789.
Done, S. J., Eskandarian, S., Bull, S., Redston, M., and Andrulis, I. L. (2001) p53 missense mutations in microdissected high-grade ductal carcinom in situ of the breast. J. Natl. Cancer Inst. 93, 700–704.
Peltomaki, P. (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum. Mol. Genet. 10, 735–740.
Young, J., Leggett, B., Gustafson, C., et al. (1993) Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum. Mutat. 2, 351–354.
Iino, H., Simms, L., Young, J., et al. (2000) DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut 47, 37–42.
Jass, J. R., Young, J., and Leggett, B. A. (2000) Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology 37, 295–301.
Gryfe, R., Kim, H., Hsieh, E. T. K., et al. (2000) Tumor microsatellite instability and patient survival in a population-based series of young colorectal cancer patients. N. Engl. J. Med. 342, 69–77.
Kern, S. E. (2001) Progressive genetic abnormalities in human neoplasia, in The Molecular Basis of Cancer (Mendelsohn, J., Howley, P. M., Israel, M. A., and Liotta, L. A., eds.). Saunders, Philadelphia, pp. 41–69.
Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., et al. (1996) Laser capture microdissection. Science 274, 998–1001.
Simone, N. L., Paweletz, C. P., Charbonneau, L., Petricoin, E. F. 3rd, and Liotta, L. A. (2000) Laser capture microdissection: beyond functional genomics to proteomics. Mol. Diagn. 5, 301–307.
Craven, R. A. and Banks, R. E. (2001) Laser capture microdissection and proteomics: possibilities and limitation. Proteomics 1, 1200–1204.
Kern, S. E., Redston, M., Seymour, A. B., et al. (1994) Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 107, 420–428.
Redston, M. S., Papadopoulos, N., Caldas, C., Kinzler, K. W., and Kern, S. E. (1995) Common occurrence of APC and K-Ras mutations in the spectrum of lesions in colitis-associated neoplasia. Gastroenterology 108, 383–392.
Barrett, M. T., Sanchez, C. A., Prevo, L. J., et al. (1999) Evolution of neoplastic cell lineages in Barrett oesophagus. Nat. Genet. 22, 106–109.
Mirabelli-Primadahl, L., Gryfe, R., Kim, H., et al. Beta-catenin mutations are common in colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathways. Cancer Res. 59, 3346–3351.
Haimowitz, M. D. (1997) Practical issues in tissue banking. Am. J. Clin. Pathol. 107, S75–S81.
Burke, H. B. and Henson, D. E. (1998) Specimen banks for prognostic factor research. Arch. Pathol. Lab. Med. 122, 871–874.
Grizzle, W. E., Aamodt, R., Clausen, K., LiVolsi, V., Pretlow, T. G., and Qualman, S. (1998) Providing human tissues for research: how to establish a program. Arch. Pathol. Lab. Med. 122, 1065–1076.
Fearon, E. R., Hamilton, S. R., and Vogelstein, B. (1987) Clonal analysis of human colorectal tumors. Science 238, 193–197.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Redston, M. (2003). Assembling a Tumor Progression Model. In: El-Deiry, W.S. (eds) Tumor Suppressor Genes. Methods in Molecular Biology™, vol 223. Humana Press. https://doi.org/10.1385/1-59259-329-1:383
Download citation
DOI: https://doi.org/10.1385/1-59259-329-1:383
Publisher Name: Humana Press
Print ISBN: 978-0-89603-987-2
Online ISBN: 978-1-59259-329-3
eBook Packages: Springer Protocols